Cover
Vol. 4 No. 1 (2026)

Published: June 1, 2026

Pages: 91-110

Review Article

Nanotechnology in Multifunctional Anti-Dandruff Shampoos: Synergistic Role of Keratolytic, Anti-fungal, and Herbal Agents: overview

Abstract

dandruff chronic and recurring scalp condition that characterised by excessive flaking, itching. Overactive sebaceous glands, microbial imbalance, impaired skin barrier function, and susceptibility to infection are among the overlapping causative factors that distinguish it from seborrheic dermatitis. Malassezia fungi, particularly Malassezia pityriasis, play a crucial role in the pathogenesis of dandruff by metabolizing lipids, releasing inflammatory mediators, and disrupting the stratum corneum barrier. Antifungal, exfoliating, and anti-inflammatory ingredients such as ketoconazole, zinc pyrithione, selenium sulfide, and salicylic acid are frequently found in conventional anti-dandruff shampoos. However, these formulations are limited by their low bioavailability, short duration on the scalp, poor penetration into the hair follicles, and the potential for irritation with prolonged use. Recent advances in nanotechnology have enabled the development of novel drug delivery systems, such as liposomes, solid lipid nanoparticles, lipid nanocarriers, polymer nanoparticles, microemulsifiers, and advanced exosome-based systems, significantly improving the effectiveness of anti-dandruff shampoos. In addition to reducing discomfort and the frequency of application, these nanocarriers enhance drug deposition in the scalp, target hair follicles, ensure controlled release, and stabilize active ingredients. Furthermore, herbal enhancers, including coconut oil, aloe vera, green tea and rosemary, possess synergistic antifungal, anti-inflammatory, antioxidant, and scalp barrier-repairing properties when added. Thus, by simultaneously addressing microbial overgrowth, inflammation, and scalp barrier damage, multifunctional, nanotechnology-enhanced shampoos offer an effective approach to tackling the multifactorial nature of dandruff. This review underscores the potential of nanoparticle-based anti-dandruff shampoos to increase therapeutic efficacy by highlighting recent developments, formulation considerations and evaluation techniques, related to these products.

References

  1. Borda, L. J., & Wikramanayake, T. C. (2015). Seborrheic dermatitis and dandruff: A comprehensive review. Journal of Clinical and Investigative Dermatology, 3(2), 10.13188/2373-1044.1000019.
  2. Rai N, Jain AK, Abraham J. Formulation and evaluation of herbal antidandruff shampoo containing garlic loaded solid lipid nanoparticles. Int J Pharma Res Rev. 2013 Oct;2(10):12–24.
  3. Pierard-Franchimont C, Xhauflaire-Uhoda E, Pierard GE. Revisiting dandruff. Int J Cosmet Sci. 2006;28(5):311–8
  4. Grice EA, Dawson TLJ. Host-microbe interactions: Malassezia and human skin. Curr Opin Microbiol. 2017; 40: 81–87.
  5. Saunte DML, Gaitanis G, Hay RJ. Malassezia-associated skin diseases, the use of diagnostics and treatment. Front Cell Infect Microbiol. 2020; 10: 112.
  6. Begum K, Nur F, Shahid MS. Isolation and characterization of Malasezzia species from dandruff samples and determinationof its sensitivity towards antifungal agents. Bangladesh Pharm J.2019;22(2):146-152. doi:10.3329/bpj.v22i2.42298
  7. Hamdino M, Saudy AA, El- Shahed LH, Taha M. Identification of Malassezia species isolated from some Malassezia associated skin diseases. J Med Mycol. 2022;32(4):101301. doi:10.1016/j. mycmed.2022.101301
  8. Dessinioti C, Katsambas A. Seborrheic dermatitis & dandruff : etiology, risk factors, and treatments: facts and controversies.ClinDermatol. 2013;31(4):343–51
  9. Park M, Park S, Jung WH. Skin commensal fungus malassezia and its lipases. J Microbiol Biotechnol. 2021;31(5):637-644. doi:10.4014/ jmb.2012.12048
  10. Keragala R, Kasunsiri TD, Kempitiya KS, Kumarapeli NN, Kumara K, Gunathilaka SS. A study on the extent, aetiology and associated factors of dandruff in a group of medical students and the in vitro effects of antidandruff preparations. Sri Lankan J Infect Dis. 2020;10(2):134. doi:10.4038/sljid.v10i2.8291
  11. Poojary PV, Sarkar S, Poojary AA, Mallya P, Selvaraj R, Koteshwara A, Aranjani JM, Lewis S. Novel anti-dandruff shampoo incorporated with ketoconazole-coated zinc oxide nanoparticles using green tea extract. J Cosmet Dermatol. 2023;22(12):e16027. doi:10.1111/jocd.16027.
  12. Anastassakis K. Androgenetic Alopecia from A to Z. Springer International Publishing; 2022. doi:10.1007/978- 3- 031- 08057- 9
  13. Garg A, Singh C, Pradhan D, Ghosh G, Rath G. Topical application of nanoparticles integrated supramolecular hydrogels for the potential treatment of seborrhoeic dermatitis. Pharm Dev Technol.2020;25(6):748-756. doi:10.1080/10837450.2020.1740932
  14. Tajran J, Gosman AA. Anatomy, Head and Neck, Scalp. [Updated 2023 Jul 24]. In: StatPearls Treasure Island (FL): StatPearls Publishing;2025Jan-.
  15. Martel JL, Miao JH, Badri T, et al. Anatomy, Hair Follicle. [Updated 2024 Jun 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;2025Jan-
  16. Thiboutot D, et al. Human sebaceous gland physiology. J Invest Dermatol. 2014;123(1):1-12.
  17. Murphrey MB, Agarwal S, Zito PM. Anatomy, Hair. [Updated 2023 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;2025Jan-.
  18. Yu H, Li J, Wang Y, Zhang T, Mehmood T, Habimana O. Dysbiosis and genomic plasticity in the oily scalp microbiome: a multi-omics analysis of dandruff pathogenesis. Front Microbiol. 2025;16:1595030. DOI: 10.3389/fmicb.2025.1595030.
  19. Jung WH. Alteration in skin mycobiome due to atopic dermatitis and seborrheic dermatitis. Biophys Rev (Melville). 2023;4(1):011309.
  20. Xiang Y, Li S, Chen Z, et al. Barrier dysfunction in dandruff: analysis of ceramides and TEWL in affected scalp. Skin Pharmacol Physiol. 2022;35(4):229–38
  21. Choi H, Lee Y, Kwon OS. Seasonal variation and inflammatory biomarkers in dandruff. Int J Mol Sci. 2022;23(5):2541.
  22. Prasad R, Chatterjee A. Environmental factors influencing dandruff severity. Clin Cosmet Investig Dermatol. 2023;16:1123–31.
  23. Borda LJ and Wikramanayake TC: Seborrheic dermatitis and dandruff: a comprehensive review. Journal of clinical and investigative dermatology 2015; 3(2)
  24. Dall'Oglio F, Nasca MR, Gerbino C, Micali G. An Overview of the Diagnosis and Management of Seborrheic Dermatitis. Clin Cosmet Investig Dermatol. 2022 Aug 6;15:1537-1548. doi: 10.2147/CCID.S284671. PMID: 35967915; PMCID: PMC9365318.
  25. Zhang Y, et al. Advances in keratolytic therapies for scalp disorders. J Cosmet Dermatol. 2022;21(7):2801-2810.
  26. Goldust M, et al. Combination therapy of salicylic acid with antifungals in dandruff management. Int J Clin Pract. 2021;75(11):e14766.
  27. Shah P, et al. Modern formulations of sulfur in dermatology. Pharmaceutics. 2020;12(8):756.
  28. Pansy FE, Stander H, Koerber WL, Donovick R. In vitro studies with 1-hydroxy-2(1H) pyridinethione. Proc Soc Exp Biol Med. 1953;82:122–124. doi: 10.3181/00379727-82-20041.
  29. Roques C, Brousse S, Panizzutti C. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains. Mycopathologia. 2006;162:395–400. doi: 10.1007/s11046-006-0075-0.
  30. Li X, et al. Nanoparticle-based zinc pyrithione for enhanced anti-dandruff efficacy. Colloids Surf B Biointerfaces. 2023;226:113293
  31. Del Rosso JQ. Ketoconazole shampoo: Current evidence and clinical uses. J Drugs Dermatol. 2020;19(9):s6-s10.
  32. Garg V, et al. Nanocarrier-based ketoconazole delivery systems for seborrheic dermatitis. Drug Dev Ind Pharm. 2021;47(10):1674-1683.
  33. Ge L, Liu Z, Xu S, Li C, Jin M, Luo Y, Kong Y, Meng J, Zheng G, Gao J, Wang P, Bai W, Na H, Zhou X, Jin Z, Pi L. A Cohort Clinical Study on the Efficacy of Topical Salicylic Acid/Piroctone Olamine Dandruff Pre-Gel and Cleanser in Improving Symptoms of Moderate to Severe Seborrheic Dermatitis of the Scalp. J Cosmet Dermatol. 2025 Jan;24(1):e16742. doi: 10.1111/jocd.16742. PMID: 39778065; PMCID: PMC11705510.
  34. Aditya S, et al. Anti-inflammatory topical agents in dandruff and seborrheic dermatitis management. Dermatol Ther. 2021;34(5):e15005.
  35. Patel S, et al. Nanotechnology-based strategies for enhanced scalp drug delivery: A modern approach to dandruff therapy. J Control Release. 2021;329:789–802.
  36. Khezri K, et al. Nano-enabled antifungal delivery systems in dermatology. Drug Deliv Transl Res. 2022;12(1):45–60.
  37. El-Rashidy AA, et al. Liposomal ketoconazole formulations for improved antifungal activity: A clinical and mechanistic evaluation. Int J Pharm. 2023;634:122658.
  38. Ahmad N, et al. Solid lipid nanoparticles for topical delivery: Advances in scalp-targeted antifungal therapy. Pharmaceutics. 2021;13(9):1420.
  39. Jores K., Haberland A., Wartewig S., Mader K., Mehnert W. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Pharm. Res. 2005;22:1887–1897. doi: 10.1007/s11095-005-7148-5.
  40. Czajkowska-Kośnik A, Szekalska M, Winnicka K. Nanostructured lipid carriers: A potential use for skin drug delivery systems. Pharmacol Reports. 2019;71(1):156–66.
  41. Dantas MG, et al. Polymeric nanoparticles for hair follicle targeting: Applications in antifungal and anti-inflammatory therapy. Colloids Surf B Biointerfaces. 2022;215:112473.
  42. Cimino C., Maurel O.M., Musumeci T., Bonaccorso A., Drago F., Souto E.M.B., Pignatello R., Carbone C. Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems. Pharmaceutics. 2021;13:327. doi: 10.3390/pharmaceutics13030327
  43. Schaffazick S.R., Guterres S.S., Freitas L.L., Pohlmann A.R. Caracterização e estabilidade fisico-química de sistemas poliméricos nanoparticulados para administração de fármacos. Química Nova. 2003;26:726–737. doi: 10.1590/S0100-40422003000500017.
  44. Derakhshandeh K., Erfan M., Dedashzadeh S. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics. Eur. J. Pharm. Biopharm. 2007;66:34–41. doi: 10.1016/j.ejpb.2006.09.004.
  45. Nastiti C, Ponto T, Abd E, Grice J, Benson H,Roberts M. Topical nano and microemulsions for skin delivery. Pharmaceutics 2017;9(4):37.
  46. Tiwari N, Sivakumar A, Mukherjee A,Chandrasekaran N. Enhanced antifungal activity of ketoconazole using rose oil basednovel microemulsion formulation. Drug DelivSci Technol. 2018;47:434–44.
  47. Amra K, Momin M. Formulation evaluation of ketoconazole microemulsion‐loaded hydrogel with nigella oil as a penetration enhancer. JCosmet Dermatol. 2019;0(0):1–9.
  48. Alam MA, Al-Janoobi FI, Alzahrani KA, Al-Agamy MH, Abdelgalil AA. In vitro efficacies of topical microemulsions of clotrimazole and ketoconazole; and in-vivo performance of clotrimazole microemulsion. J Drug Deliv Sci Technol. 2017;39:408–16.
  49. Singh M, Gangwar N, Parashar P, B Tripathi C,Arya M, A Saraf S, et al. Topical delivery of fluconazole via microemulsion incorporated hydrogel for the management of fungal dermatophytosis. Curr Drug ther.2016;11(2):129–41.
  50. Peira E, Carlotti ME, Trotta C, Cavalli R, Trotta M. Positively charged microemulsions for topical application. Int J Pharm. 2008;346(1):119–23.
  51. Shrestha S, Pokhrel S, Sharma S, Manandhar M, Alam I. Formulation and evaluation of topical microemulgel loaded with terbinafine HCl microemulsion. Int J Pharm Sci Res.2017;8(11):4716–23.
  52. Pillai AB, Nair J V, Gupta NK, Gupta S. Microemulsion-loaded hydrogel formulation of butenafine hydrochloride for improved topical delivery. Arch Dermatol Res. 2015;307(7):625–33.
  53. Badawi AA, Nour SA, Sakran WS, El-Mancy SMS. Preparation and evaluation of microemulsion systems containing salicylic acid. AAPS PharmSciTech. 2009;10(4):1081–
  54. Aljamal M, Kayal I, Abul-haj M. Topical salicylic acid and lactic acid microemulsion. Org Med Chem I J. 2017;2(3):1–5.
  55. Savić V, Todosijević M, Ilić T, Lukić M,Mitsou E, Papadimitriou V, et al. Tacrolimus loaded biocompatible lecithin-based microemulsions with improved skin penetration: structure characterization and in vitro/in vivo performances. Int J Pharm.2017;529(1):491–505.
  56. Qiu, G.; Zheng, G.; Ge, M.; Wang, J.; Huang, R.; Shu, Q.; Xu, J. Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res. Ther. 2019, 10, 359.
  57. Shamili, F.H.; Bayegi, H.R.; Salmasi, Z.; Sadri, K.; Mahmoudi, M.; Kalantari, M.; Ramezani, M.; Abnous, K. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model. Int. J. Pharm. 2018, 549, 218–229.
  58. Shin, K.-O.; Ha, D.H.; Kim, J.O.; Crumrine, D.A.; Meyer, J.M.; Wakefield, J.S.; Lee, Y.; Kim, B.; Kim, S.; Kim, H.-k.; et al. Exosomes from human adipose tissue-derived mesenchymal stem cells promote epidermal barrier repair by inducing de novo synthesis of ceramides in atopic dermatitis. Cells 2020, 9, 680.
  59. Carrasco, E.; Soto-Heredero, G.; Mittelbrunn, M. The role of extracellular vesicles in cutaneous remodeling and hair follicle dynamics. Int. J. Mol. Sci. 2019, 20, 2758
  60. Houli Li, Xiaobin Zhao, Yukun Ma and Guangxi Zhai, Ling Bing Li and Hong Xiang, Lou. J. CONT. RELEASE, 133, 238-244 (2009).
  61. Mithal B.M. and Saha R.N. A Handbook of Cosmetic Vallabh Prakashan, New Delhi, First edition,2002, 110-120.
  62. Lademann J, et al. Hair follicles as penetration pathways for nanoparticle-based drug delivery. Exp Dermatol. 2021;30(10):1459–1470.
  63. Raza K, et al. Nanotechnology for improved antidandruff formulations: Enhanced scalp deposition and efficacy. Colloids Surf B Biointerfaces. 2020;194:111204.
  64. Müller RH, et al. Controlled release from lipid nanoparticles for topical therapy. Eur J Pharm Biopharm. 2021;165:55–67
  65. Laxmi M, Singh J, Kaur H. Nanocarrier‐assisted delivery of antifungal agents for improved stability and therapeutic efficacy: A systematic review. Drug Deliv Transl Res. 2022;12(6):1324–1339.
  66. Mofidfar M, Prausnitz MR. Nanoparticle encapsulation reduces irritation and enhances targeted delivery of topical dermatologic agents. J Control Release. 2021;338:760–772.
  67. D’Souza AA, Shegokar R. Solid lipid nanoparticles for enhanced solubility and scalp delivery of lipophilic antifungal drugs. Colloids Surf B Biointerfaces. 2023;228:113420.
  68. Jaiswal P, Alam S, Singh A. Multifunctional nanocarriers co-loading antifungal and anti-inflammatory agents for the management of dandruff and seborrheic dermatitis. Pharmaceutics. 2024;16(2):215.
  69. Balakrishnan N, et al. Herbal actives in scalp care: Advances in safety and efficacy. J Cosmet Dermatol. 2021;20(8):2503–2512.
  70. Nasir F, et al. Evidence-based medicinal plants in dandruff management: A systematic review. Phytother Res. 2022;36(5):1943–1958.
  71. Varma SR, Sivaprakasam TO, Arumugam I, Dilipa N, Raghuraman M, Pavan KB, Mohammed R, Paramesh R. In vitro anti-inflammatory and skin protective properties of Virgin coconut oil. J Tradit Complement Med. 2019;9:5–14.
  72. Rele AS, Mohile RB. Penetration and protective effects of coconut oil on hair. J Cosmet Sci. 2020;71(4):235–245.
  73. Verma S, et al. Antimicrobial properties of coconut oil in scalp disorders. Int J Trichology. 2021;13(3):121–128.
  74. Alqurashi T, et al. Coconut oil as a natural penetration enhancer for topical antifungal therapy. Drug Deliv Transl Res. 2022;12(4):890–899.
  75. Al-Snafi AE. Pharmacological and traditional uses of Ziziphus spina-christi: A review. IOSR J Pharm. 2020;10(3):45–57.
  76. Ahmed F, et al. Antioxidant and antimicrobial activities of Ziziphus spina-christi extract for hair and scalp care. J Ethnopharmacol. 2021;271:113866.
  77. Alzomor AKY, Al-Madhagi WM, Sallam NM, Mojamel H, Alawar MM, Al-Hetari AG. Subacute toxicity study and clinical trials for Ziziphus spina-christi leaves extract as an anti-dandruff shampoo. Thai J Pharm Sci. 2021;45(2):Article 7. doi:10.56808/3027-7922.2482.
  78. Kwon OS, Lee YJ, Kim HJ, Park JH, Choi SY, Seo YJ. Epigallocatechin-3-gallate as a 5α-reductase inhibitor and hair growth promoter: molecular mechanisms and therapeutic potential. Phytomedicine. 2024;109:154556.
  79. Noviani V, Thauresia S, Apriani EF, Simanjuntak P. Hair growth promoting activity of green tea leaves (Camellia sinensis L.) ethanolic extract. Trad Med J. 2019;24(2):104–109.
  80. Dive A, Pandav A, Chougule N. Aloe-Vera in Hair Cosmetics: A Comprehensive Overview. IJIRT. 2024 Jan;10(8):[page numbers if available]. ISSN: 2349-6002.
  81. Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparativetrial. Skinmed. 2015; 13(1):15-21.
  82. Satyalakshmi S, Srinivasa Rao Y, Bhoomika M, Kamala Kumari PV. Rosmarinus officinalis: Hair, skin and other possible therapeutic activities. IJBPAS. 2025 Oct;14(10):5180-5189. doi: 10.31032/IJBPAS/2025/14.10.9136. ISSN: 2277–4998.
  83. Chaudhary S, et al. Synergistic enhancement of antidandruff agents using herbal extracts. Pharmaceutics. 2022;14(7):1456.
  84. Kumar V, et al. Multifunctional shampoos integrating herbal and conventional actives: A mechanistic review. J Cosmet Sci. 2023;74(2):99–112.
  85. Vairagade Y. A comprehensive review on the formulation, evaluation, and future prospects of herbal shampoo. Int J Pharm Sci. 2025;3(3):3322–3342.
  86. Singh A, Patel R. Natural surfactants and their application in shampoo formulations: A review. Int J Herb Cosmet Pharm Res. 2025;6(1):45–60.
  87. Gupta S, Kumar V. Rheological modifiers in cosmetic shampoo bases: theory and application. Cosmet Sci Technol J. 2025;12(4):215–232.
  88. Sharma P, Reddy K. Nanoparticle–herb interactions in topical formulations: compatibility and stability. J Nanocosmetics. 2024;8(2):101–119.
  89. Das S, Nayak AK. pH optimization in nanoemulsion shampoo systems: effects on stability and delivery. Colloids Surf B Biointerfaces. 2025;234:113750.
  90. Lee H, Park J. Charge and surface modification strategies for nanoparticulate scalp delivery. Int J Pharm. 2024;610:121290.
  91. Verma M, Jain S. Safety considerations in nano‑cosmeceuticals: current challenges and solutions. Dermatol Ther. 2025;38(3):e14922.
  92. Kumar A, Singh D. In vitro characterization techniques for nano‑shampoo formulations. Pharm Methods. 2025;16:52–68.
  93. Rodriguez A, Kim S. Advances in follicular penetration assessment for cosmetic nanoparticles. Skin Pharmacol Physiol. 2024;37(6):283–297.
  94. Chen Y, Liu Y. Ex vivo scalp penetration and imaging of hair follicle targeting systems. J Cosmet Dermatol. 2025;24(2):512–525.
  95. Patel P, Shah M. Clinical efficacy evaluation of multifunctional anti‑dandruff shampoos: methodology and outcomes. Dermatol Pract Concept. 2025;15(1):e2025012.
  96. Banerjee S, Roy P. Irritation and patch testing requirements for novel topical systems. Clin Cosmet Investig Dermatol. 2024;17:145–160.
  97. Hussein M, Ahmed R. Cytotoxicity profiling of cosmetic nanoformulations on human skin cell lines. Toxicol In Vitro. 2025;83:105444.
  98. Singh R, Kapoor A. Sensitization risk assessment in nano‑enabled topical products. Regul Toxicol Pharmacol. 2025;134:105253.
  99. European Commission. Scientific Committee on Consumer Safety (SCCS) opinion on nanomaterials in cosmetics. Official J EU. 2025;C‑234/1–C‑234/35.
  100. FDA Draft Guidance for Industry: Safety of Nanotechnology in Cosmetic Products. U.S. Food and Drug Administration (2025).
  101. Singh Y, Meher JG, Raval K. Challenges in stability of lipid and polymeric nanoparticle systems for topical delivery. Colloids Surf B Biointerfaces. 2022;218:112761.
  102. Mohammed YH, Holmes A, Grice JE. Safety and cytotoxicity considerations of nanoparticles in dermal and follicular delivery. J Control Release. 2021;336:652–670.
  103. Fernandes AR, Sanchez-Lopez E, Garcia ML. Interaction of nanocarriers with cosmetic surfactants: Implications for stability and drug release in shampoo formulations. Int J Pharm. 2023;643:123200.
  104. de Oliveira AM, Souto EB, Silva AM. Overcoming formulation challenges in nano-enabled dermatologic products. Pharmaceutics. 2024;16(3):455.